THE Australian Competition and Consumer Commission (ACCC) has launched Federal Court proceedings against GSK Australia and Novartis Consumer Health Australasia, alleging they made "false or misleading representations in the marketing of Voltaren Osteo Gel and Voltaren Emulget pain relief products".
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 06 Dec 17
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Dec 17
